Fosamax and Boniva linked to dental complications

Drawing of a toothOsteonecrosis of the jaw, as a complication of dental procedures, has occurred in 4% of patients taking oral alendronate (Fosamax), whereas none of those who didn’t take the drug experienced any complications.

Fosamax, as well as Boniva and Actonel, are oral bisphosphonates.   Fosamax is the most widely prescribed oral bisphosphonate, and in 2006 it was the 21st most prescribed drug overall. 

In an article in MedPage Today, the the researchers are quoted as saying, “…if patients are using bisphosphonates, dentists should consider alternate treatment options for non-necessary extractions and good oral hygiene should be achieved before extractions to minimize microbial load. Also, follow-up should be more vigilant and a chlorhexidine rinse pre- and post-operatively ‘can be effective’ in ensuring socket and wound healing and mucosal coverage of exposed bone…”

These findings are preliminary, but if you’re taking any one of the bisphosphonates, be sure to let your dentist know, especially before any dental procedures.

via MedPage Today, January 2009

Bookmark Bookmark this page
E-mail E-mail this story
Print this post Print this post

2 Responses to “Fosamax and Boniva linked to dental complications”


  1. This is a very interesting post about fosamax and boniva. Many are lots of people who are not aware about their effects on the body. Now, we should be cautious about their dental condition. Only experts know what is right for you, but what about the dental practitioner puts you into peril? This is not good. Posts, such as this gives you a “warning sign” and the “truth” behind those medications being given to you.

  2. It is interesting and informative! It just shows how interconnected our overall health with dental health. I never knew that fosamax and boniva are linked to dental complications.

Leave a Reply

Currently you have JavaScript disabled. In order to post comments, please make sure JavaScript and Cookies are enabled, and reload the page.